ANI Pharmaceuticals Inc (ANIP) support and resistance · rev $503.5M
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
This page maps ANI Pharmaceuticals Inc (ANIP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
ANIP currently screens at market cap $1.41B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ANIP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ANIP quote page for the session range and the stock page for the full model.
Not investment advice.